9-ME-BC

• Dry-fill capsules (20mg per capsule)
• 1-gram raw powder

Findings from experimental models suggest that 9-ME-BC may: These actions make 9-ME-BC of interest in cognition, focus, mood regulation, and neuroprotective research.

• Inhibit MAO activity, influencing dopamine and other monoamine turnover
• Increase dopamine-associated signaling in hippocampal and dopaminergic models
• Support neurotrophic factor expression in glial and neuronal systems
• Promote dendritic and synaptic plasticity signals in cognition-related models
• Reduce inflammatory signaling markers in select neurostress paradigms

Researchers typically explore 9-ME-BC for

• Improved focus and cognitive task performance signals in preclinical models
• Increased motivation and drive in dopaminergic contexts
• Support for neuroprotective and neurorestorative signaling in dopamine-stressed models
• Potential mood and resilience support related to monoamine balance in research discussions

Reported findings include: Researchers typically avoid combining 9-ME-BC with dopaminergic stimulants due to potential synergistic effects.

• Hyperthermia risk signals and elevated body temperature markers
• Tachycardia and cardiovascular strain signals and reduced exercise tolerance endpoints
• Excessive fatigue and malaise like behavior in animal models
• Dehydration risk markers secondary to heat stress
• Mitochondrial stress responses at higher exposures, including impaired cellular function endpoints

Caution is warranted in research applications when combined with

• Strong dopaminergic stimulants (amphetamine analogs, modafinil, etc.)
• High-dose MAO inhibitors